Jubilant Life Sciences Ltd.

Indian companies saw continued erosion of generic drug prices in the US during the second quarter of fiscal year 2023, which ends 31 March, management commentary from companies which have announced ea

Indian companies saw continued erosion of generic drug prices in the US during the second quarter of fiscal year 2023, which ends 31 March, management commentary from companies which have announced ea

Jubilant Pharmova is planning a “transformation” for its generics business after announcing the appointment of Jaidev Rajpal as managing director and CEO of Jubilant Generics from 11 October. Rajpal

Much of the world’s attention over the past few weeks has been captured by monkeypox after its presence in over 90 non-endemic countries pushed the World Health Organization (WHO) to declare a public